These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2166243)

  • 1. Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions.
    Ruberg M; Mayo W; Brice A; Duyckaerts C; Hauw JJ; Simon H; LeMoal M; Agid Y
    Neuroscience; 1990; 35(2):327-33. PubMed ID: 2166243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline acetyltransferase activity and vesamicol binding in Rett syndrome and in rats with nucleus basalis lesions.
    Wenk GL; Mobley SL
    Neuroscience; 1996 Jul; 73(1):79-84. PubMed ID: 8783231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]vesamicol binding in human brain cholinergic deficiency disorders.
    Kish SJ; Distefano LM; Dozic S; Robitaille Y; Rajput A; Deck JH; Hornykiewicz O
    Neurosci Lett; 1990 Sep; 117(3):347-52. PubMed ID: 2151294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease.
    Sihver W; Gillberg PG; Svensson AL; Nordberg A
    Neuroscience; 1999; 94(3):685-96. PubMed ID: 10579560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions.
    Maragos WF; Greenamyre JT; Chu DC; Penney JB; Young AB
    Brain Res; 1991 Jan; 538(1):36-45. PubMed ID: 1850317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.
    Beal MF; Clevens RA; Chattha GK; MacGarvey UM; Mazurek MF; Gabriel SM
    J Neurochem; 1988 Dec; 51(6):1935-41. PubMed ID: 2460590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminergic systems in Alzheimer's disease and Parkinson's disease.
    D'Amato RJ; Zweig RM; Whitehouse PJ; Wenk GL; Singer HS; Mayeux R; Price DL; Snyder SH
    Ann Neurol; 1987 Aug; 22(2):229-36. PubMed ID: 3477996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions.
    Altar CA; Marien MR
    Synapse; 1988; 2(5):486-93. PubMed ID: 2973145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol.
    Jung YW; Frey KA; Mulholland GK; del Rosario R; Sherman PS; Raffel DM; Van Dort ME; Kuhl DE; Gildersleeve DL; Wieland DM
    J Med Chem; 1996 Aug; 39(17):3331-42. PubMed ID: 8765517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases.
    Cross AJ; Slater P; Simpson M; Royston C; Deakin JF; Perry RH; Perry EK
    Neurosci Lett; 1987 Aug; 79(1-2):213-7. PubMed ID: 2823192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183).
    Marien MR; Parsons SM; Altar CA
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):876-80. PubMed ID: 3468515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ
    Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
    Palmer AM; Gershon S
    FASEB J; 1990 Jul; 4(10):2745-52. PubMed ID: 2165009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyglucose uptake and choline acetyltransferase activity in cerebral cortex following lesions of the nucleus basalis magnocellularis.
    Lamarca MV; Fibiger HC
    Brain Res; 1984 Jul; 307(1-2):366-9. PubMed ID: 6540615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between the effects of basal forebrain lesions and chronic treatment with MDL 26,479 on learning and markers of cholinergic transmission.
    Holley LA; Miller JA; Chmielewski PA; Dudchenko P; Sarter M
    Brain Res; 1993 May; 610(2):181-93. PubMed ID: 8391369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.
    Rinne JO; Lönnberg P; Marjamäki P; Rinne UK
    Brain Res; 1989 Apr; 483(2):402-6. PubMed ID: 2706531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vagal autotransplantation on quantitative [3H]-vesamicol binding image in rats with unilateral lesions of nucleus baslis magnocellularis.
    Ikeda E; Ichikawa A; Mori H; Shiba K; Kuji I; Sumiya H; Tonami N; Ikeda K
    Neurosci Lett; 2001 Mar; 300(1):33-6. PubMed ID: 11172933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
    Perry RH; Perry EK; Smith CJ; Xuereb JH; Irving D; Whitford CA; Candy JM; Cross AJ
    J Neural Transm Suppl; 1987; 24():131-6. PubMed ID: 2824687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor receptor immunoreactivity within the nucleus basalis (Ch4) in Parkinson's disease: reduced cell numbers and co-localization with cholinergic neurons.
    Mufson EJ; Presley LN; Kordower JH
    Brain Res; 1991 Jan; 539(1):19-30. PubMed ID: 1849779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the vesamicol receptor in cholinergic synaptic vesicles by acetylcholine and an endogenous factor.
    Noremberg K; Parsons SM
    J Neurochem; 1989 Mar; 52(3):913-20. PubMed ID: 2537382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.